← Leaderboards
Debanjan Dhar
University Of California, San Diego
$3,366,301
Attributed
$3,366,301
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,366,301 · 2
By mechanism
R01$3,366,301 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Michael Karin$60,628,305
- Lev S Tsimring$8,030,038
- Andrew P Goodwin$4,571,484
- Yuan Chen$18,343,172
- Christian Michael Metallo$6,622,491
Others in their field
Other Rising Stars on “Liver Injury”
- Paul Tang · University Of Michigan At Ann Arbor$4,692,033
- Abraham Teunissen · Icahn School Of Medicine At Mount Sinai$2,690,545
- Robert Nathaniel Helsley · University Of Kentucky$2,651,504
- Hyunwoo Yuk · Sanaheal, Inc.$2,498,634
- Paris Margaritis · Geneventiv Therapeutics, Inc.$2,496,892
- Zhangjie Wang · Glycan Therapeutics Corporation$2,387,583
Research focus
Liver InjuryNew Therapeutic TargetFoundationsLiverMetabolic SyndromeMutationDietFibrosisFunctional DisorderHepatocyteMalignant Neoplasm Of LiverMediatingMissionMouse Model3-DimensionalChronic Liver InflammationDisease ProgressionFatty Liver DiseaseCellsAffectFutureHealth Care CostsLiver TransplantationNon-Alcoholic Fatty Liver Disease
Grant awards (6)
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.$665,028
R01 · FY2025 · DK · contact PI
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases$500,000
R01 · FY2025 · DK · contact PI
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.$661,236
R01 · FY2024 · DK · contact PI
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases$480,000
R01 · FY2024 · DK · contact PI
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.$560,037
R01 · FY2023 · DK · contact PI
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases$500,000
R01 · FY2023 · DK · contact PI